# Jeffrey M. Kaplan, M.D. – FDA Inspection, Sep 20, 2024

Source: https://www.keypedia.com/records/fda_inspections/jeffrey-m-kaplan-md/d5bfe8a2-b8f4-4bea-b070-4708fcf5d82e
Source feed: FDA_Inspections

> FDA inspection 1249701 of Jeffrey M. Kaplan, M.D., September 20, 2024. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR parts 50 and 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1249701
- Company Name: Jeffrey M. Kaplan, M.D.
- Inspection Date: 2024-09-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Kansas City District Office
- Citation Count: 4

## Related Officers

- [Company Rep](https://www.keypedia.com/people/karen-m-montgomery/ee91b1bb-8d51-4fdc-bee5-949441136e59)

Company: https://www.keypedia.com/companies/jeffrey-m-kaplan-md/1c63176f-581f-403e-8827-484a387e04bc

Office: https://www.keypedia.com/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79